Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Gaudet

Showing results (41-50 of 304) with videos related to

Pageof 31
Sort By:
Frontiers in Genetics|May 6, 2014
Association of CTRC and SPINK1 gene variants with recurrent hospitalizations for pancreatitis or acute abdominal pain in lipoprotein lipase deficiencyKarine Tremblay, Camélia Dubois-Bouchard, Diane Brisson, et al.
Orphanet Journal of Rare Diseases|June 27, 2023
Post-prandial analysis of fluctuations in the platelet count and platelet function in patients with the familial chylomicronemia syndromeMiriam Larouche, Diane Brisson, Marie-Claude Morissette, et al.
Menopause (New York, N.Y.)|January 22, 2011
Contribution of adiponectin to the cardiometabolic risk of postmenopausal women with loss-of-function lipoprotein lipase gene mutationsYacine Loucif, Julie Méthot, Karine Tremblay, et al.
Circulation Research|June 4, 2026
New and Emerging Therapeutic Targets for ApoB-Containing Particles LoweringDaniel Gaudet, Miriam Larouche, Frederick J Raal, et al.
Community Genetics|October 20, 2001
Ethical issues in molecular screening for heterozygous familial hypercholesterolemia: the complexity of dealing with genetic susceptibility to coronary artery diseaseDaniel Gaudet, Claude Gagné, Patrice Perron, et al.
Clinical Biochemistry|February 13, 2023
Correlation between chylomicronemia diagnosis scores and post-heparin lipoprotein lipase activityDiane Brisson, Miriam Larouche, Jasmine Chebli, et al.
Journal of the Endocrine Society|March 6, 2025
Treatment With Evinacumab Links a New Pathogenic Variant in the LPL Gene to Persistent ChylomicronemiaMiriam Larouche, Poulabi Banerjee, Diane Brisson, et al.
Journal of Clinical Lipidology|October 9, 2020
Relative effect of hypertriglyceridemia on non-HDLC and apolipoprotein B as cardiovascular disease risk markersCathy J Sun, Diane Brisson, Daniel Gaudet, et al.
Journal of Clinical Medicine|December 30, 2020
Identifying Markers of Cardiovascular Event-Free Survival in Familial HypercholesterolemiaEtienne Khoury, Diane Brisson, Nathalie Roy, et al.
Expert Opinion on Drug Safety|April 5, 2019
Review of the long-term safety of lomitapide: a microsomal triglycerides transfer protein inhibitor for treating homozygous familial hypercholesterolemiaEtienne Khoury, Diane Brisson, Nathalie Roy, et al.
Pageof 31

Showing results (41-50 of 304) with videos related to

Sort By:
Pageof 31
Frontiers in Genetics|May 6, 2014
Association of CTRC and SPINK1 gene variants with recurrent hospitalizations for pancreatitis or acute abdominal pain in lipoprotein lipase deficiencyKarine Tremblay, Camélia Dubois-Bouchard, Diane Brisson, et al.
Orphanet Journal of Rare Diseases|June 27, 2023
Post-prandial analysis of fluctuations in the platelet count and platelet function in patients with the familial chylomicronemia syndromeMiriam Larouche, Diane Brisson, Marie-Claude Morissette, et al.
Menopause (New York, N.Y.)|January 22, 2011
Contribution of adiponectin to the cardiometabolic risk of postmenopausal women with loss-of-function lipoprotein lipase gene mutationsYacine Loucif, Julie Méthot, Karine Tremblay, et al.
Circulation Research|June 4, 2026
New and Emerging Therapeutic Targets for ApoB-Containing Particles LoweringDaniel Gaudet, Miriam Larouche, Frederick J Raal, et al.
Community Genetics|October 20, 2001
Ethical issues in molecular screening for heterozygous familial hypercholesterolemia: the complexity of dealing with genetic susceptibility to coronary artery diseaseDaniel Gaudet, Claude Gagné, Patrice Perron, et al.
Clinical Biochemistry|February 13, 2023
Correlation between chylomicronemia diagnosis scores and post-heparin lipoprotein lipase activityDiane Brisson, Miriam Larouche, Jasmine Chebli, et al.
Journal of the Endocrine Society|March 6, 2025
Treatment With Evinacumab Links a New Pathogenic Variant in the LPL Gene to Persistent ChylomicronemiaMiriam Larouche, Poulabi Banerjee, Diane Brisson, et al.
Journal of Clinical Lipidology|October 9, 2020
Relative effect of hypertriglyceridemia on non-HDLC and apolipoprotein B as cardiovascular disease risk markersCathy J Sun, Diane Brisson, Daniel Gaudet, et al.
Journal of Clinical Medicine|December 30, 2020
Identifying Markers of Cardiovascular Event-Free Survival in Familial HypercholesterolemiaEtienne Khoury, Diane Brisson, Nathalie Roy, et al.
Expert Opinion on Drug Safety|April 5, 2019
Review of the long-term safety of lomitapide: a microsomal triglycerides transfer protein inhibitor for treating homozygous familial hypercholesterolemiaEtienne Khoury, Diane Brisson, Nathalie Roy, et al.
Pageof 31